In This Episode

In this episode, Lee Bowman, COO of Mediphage, explores the intersection of gene therapy, AI, and digital transformation in biotech. With a strong focus on operational excellence, he leads cross-functional teams, manages budgets, and fosters key stakeholder relationships to drive groundbreaking gene therapy technologies.

Bowman discusses how innovation is accelerating drug development, the role of strategic partnerships, and the challenges facing small biotech companies. He also shares insights on overcoming industry limitations and the future of personalized medicine. Tune in for a compelling discussion on the advancements shaping the next generation of healthcare.

 

Revolutionize Your Biomanufacturing with Katalyze AI

Experience how Katalyze AI’s platform can transform your operations by enhancing yield, improving traceability, and reducing cycle times across your biopharma processes.

Here’s What You Can Achieve:

• Up to 8% Yield Increase: Minimize deviations and optimize quality with AI-powered digital twins tailored to your processes.
• 40% Faster Batch Release: Streamline raw material quality control by automating data consolidation and specification checks.
• Save Up to 4 Hours on Investigations: Leverage a unified source of truth for raw material and process data to quickly identify root causes and draft reports.

Get Your Free Demo Today

Curious about how Katalyze AI can elevate your manufacturing operations? Fill out the form, and our team will provide a tailored demonstration to discuss solutions specific to your needs.

Key Features Include:

• More Than 10+ out-of-the-box Integrations
• Access to Katalyze AI's Large Biologic Models
• Science-Backed Yield and Quality Improvement

Book Your Free Demo Now